Option chain shows key data for Intelligent Bio Solutions's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Intelligent Bio Solutions.

Intelligent Bio Solutions (NASDAQ:INBS) Stock, Option Chain

Intelligent Bio Solutions

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).

INBS

Earnings

News

Health Care

Exclusives

General

Intelligent Bio Solutions Inc. - Common Stock

Intelligent Bio Solutions reports rising sales and profit margins, driven by recurring revenue from cartridge sales and global expansion through key partnerships.

EXCLUSIVE: Intelligent Bio Solutions Expects To Record Increased Profitability In Q2 On Higher-Margin Sales

Quantum Traffic Management adopts INBS&#39; Intelligent Fingerprinting Drug Testing Solution to improve efficiency and safety, with plans to expand in US.

EXCLUSIVE: Intelligent Bio Solutions Partners With UK-Based Quantum TM For Fingerprint Drug Testing At 10 Sites

Contracts

Market-Moving Exclusives

Intelligent Bio Solutions collaborates with IVY Diagnostics to enhance drug screening adoption in Europe and the Middle East, targeting key regions.

EXCLUSIVE: Intelligent Bio Solutions Partners With IVY Diagnostics, Seeks Expansion In Europe&#39;s $3.6 Billion Drug Screening Market

Intelligent Bio Solutions Inc

Press Releases

Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029

Intelligent Bio Solutions Expands Global Reach with Multilingual Drug Screening System Upgrade

Intelligent Bio Solutions expects to achieve 32.6% Gross Profit Expansion and Increased Profitability on Higher-Margin Sales

Intelligent Bio Solutions Expands with UK Partnership, Driving Global Growth Ahead of Planned U.S. Launch

Intelligent Bio Solutions Releases Shareholder Letter Detailing 2024 Growth and 2025 U.S. Expansion Strategy

Intelligent Bio Solutions Announces Fiscal Q2 2025 Financial Results and Key Operational Achievements

Intelligent Bio Solutions Inc. Announces Proposed Public Offering of Common Stock

Financing

Intelligent Bio Solutions Inc. Announces Pricing of $2.6 Million Public Offering of Common Stock

Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriter's Option to Purchase Additional Shares of Common Stock

Intelligent Bio Solutions to Participate in the iAccess Virtual Best Ideas Spring Conference on March 25th and 26th

BIAF

CDIO

SOBR

TRIB

Adagio Medical Holdings, Inc - Common Stock

Adagio Medical Holdings

Aethlon Medical

Autonomix Medical

Accelerate Diagnostics, Inc. - Common Stock

Accelerate Diagnostics

Biomerica

BioSig Technologies

Envoy Medical, Inc. - Class A Common Stock

Envoy Medical

Co-Diagnostics

DIH Holding US, Inc. - Class A Common Stock

DIH Holding US

Ekso Bionics Holdings, Inc. - Common Stock

Ekso Bionics Holdings

Femasys

SeaStar Medical Holding Corporation - Common Stock

SeaStar Medical Holding

Iridex

Know Labs

NanoVibronix

NeuroOne Medical Technologies Corporation - Common Stock

NeuroOne Medical Tech

NeuroMetrix

Nuwellis

Nexalin Technology

PAVmed

Predictive Oncology

Strata Skin Sciences, Inc. - Common Stock

Strata Skin Sciences

Trinity Biotech plc - American Depositary Shares

Trinity Biotech

Beyond Air

Xylo Technologies Ltd. - American Depositary Shares

Comments

Intelligent Bio Solutions

Intelligent Bio Solutions (INBS) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga